Procept Biorobotics Corp Stock Analysis
PRCT Stock | USD 95.59 1.70 1.75% |
Procept Biorobotics Corp is overvalued with Real Value of 75.03 and Target Price of 46.38. The main objective of Procept Biorobotics stock analysis is to determine its intrinsic value, which is an estimate of what Procept Biorobotics Corp is worth, separate from its market price. There are two main types of Procept Biorobotics' stock analysis: fundamental analysis and technical analysis.
The Procept Biorobotics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Procept Biorobotics is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Procept Stock trading window is adjusted to America/New York timezone.
Procept |
Procept Stock Analysis Notes
About 86.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.95. Procept Biorobotics Corp had not issued any dividends in recent years. PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. Procept Biorobotics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 234 people. To find out more about Procept Biorobotics Corp contact Reza Zadno at 650 232 7200 or learn more at https://www.procept-biorobotics.com.Procept Biorobotics Quarterly Total Revenue |
|
Procept Biorobotics Corp Investment Alerts
Procept Biorobotics had very high historical volatility over the last 90 days | |
The company reported the previous year's revenue of 136.19 M. Net Loss for the year was (105.9 M) with profit before overhead, payroll, taxes, and interest of 37.09 M. | |
Procept Biorobotics Corp currently holds about 269.81 M in cash with (108 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.05. | |
Over 86.0% of the company shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: PROCEPT BioRobotics Corporation Gains 40 percent Following Strong Q3 Earnings and Upgraded Guidance |
Procept Biorobotics Corp Upcoming and Recent Events
27th of February 2024 Upcoming Quarterly Report | View | |
25th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Procept Largest EPS Surprises
Earnings surprises can significantly impact Procept Biorobotics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2022-08-04 | 2022-06-30 | -0.48 | -0.43 | 0.05 | 10 | ||
2022-05-05 | 2022-03-31 | -0.47 | -0.39 | 0.08 | 17 | ||
2024-10-30 | 2024-09-30 | -0.49 | -0.4 | 0.09 | 18 |
Procept Biorobotics Environmental, Social, and Governance (ESG) Scores
Procept Biorobotics' ESG score is a quantitative measure that evaluates Procept Biorobotics' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Procept Biorobotics' operations that may have significant financial implications and affect Procept Biorobotics' stock price as well as guide investors towards more socially responsible investments.
Procept Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Franklin Resources Inc | 2024-09-30 | 886 K | Jpmorgan Chase & Co | 2024-09-30 | 812.4 K | T. Rowe Price Associates, Inc. | 2024-09-30 | 777.4 K | Lord, Abbett & Co Llc | 2024-09-30 | 748.6 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 650.8 K | Champlain Investment Partners, Llc | 2024-09-30 | 650.3 K | Bank Of America Corp | 2024-06-30 | 647.2 K | Mirae Asset Global Etfs Holdings Ltd. | 2024-09-30 | 638.5 K | Bellevue Group Ag | 2024-09-30 | 612.7 K | Fmr Inc | 2024-09-30 | 7.3 M | Vanguard Group Inc | 2024-09-30 | 4.8 M |
Procept Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.26 B.Procept Profitablity
The company has Profit Margin (PM) of (0.5) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.38) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.38.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.26) | (0.28) | |
Return On Capital Employed | (0.30) | (0.32) | |
Return On Assets | (0.26) | (0.27) | |
Return On Equity | (0.38) | (0.36) |
Management Efficiency
Procept Biorobotics Corp has return on total asset (ROA) of (0.1673) % which means that it has lost $0.1673 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3702) %, meaning that it created substantial loss on money invested by shareholders. Procept Biorobotics' management efficiency ratios could be used to measure how well Procept Biorobotics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.28 in 2024. Return On Capital Employed is likely to drop to -0.32 in 2024. At this time, Procept Biorobotics' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 26.1 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 5.94 | 6.24 | |
Tangible Book Value Per Share | 5.92 | 6.21 | |
Enterprise Value Over EBITDA | (18.37) | (19.29) | |
Price Book Value Ratio | 7.05 | 7.41 | |
Enterprise Value Multiple | (18.37) | (19.29) | |
Price Fair Value | 7.05 | 7.41 | |
Enterprise Value | 1.6 B | 1.4 B |
Procept Biorobotics showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Operating Margin (0.38) | Profit Margin (0.50) | Beta 1.005 | Return On Assets (0.17) | Return On Equity (0.37) |
Technical Drivers
As of the 2nd of December, Procept Biorobotics holds the Risk Adjusted Performance of 0.0672, semi deviation of 2.5, and Coefficient Of Variation of 1301.49. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Procept Biorobotics, as well as the relationship between them.Procept Biorobotics Corp Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Procept Biorobotics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Procept Biorobotics Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Procept Biorobotics Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Procept Biorobotics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Procept Biorobotics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Procept Biorobotics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Procept Biorobotics Outstanding Bonds
Procept Biorobotics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Procept Biorobotics Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Procept bonds can be classified according to their maturity, which is the date when Procept Biorobotics Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
PROCTER GAMBLE 645 Corp BondUS742718BH18 | View | |
US742718AV11 Corp BondUS742718AV11 | View | |
PROCTER GAMBLE 55 Corp BondUS742718CB39 | View | |
PROCTER GAMBLE 555 Corp BondUS742718DF34 | View | |
PROCTER GAMBLE 58 Corp BondUS742718DB20 | View | |
PROCTER GAMBLE 245 Corp BondUS742718ER62 | View |
Procept Biorobotics Predictive Daily Indicators
Procept Biorobotics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Procept Biorobotics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Procept Biorobotics Corporate Filings
F4 | 22nd of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 15th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 7th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 4th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 31st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
30th of October 2024 Other Reports | ViewVerify |
Procept Biorobotics Forecast Models
Procept Biorobotics' time-series forecasting models are one of many Procept Biorobotics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Procept Biorobotics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Procept Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Procept Biorobotics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Procept shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Procept Biorobotics. By using and applying Procept Stock analysis, traders can create a robust methodology for identifying Procept entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.78) | (0.82) | |
Operating Profit Margin | (0.80) | (0.84) | |
Net Loss | (0.78) | (0.82) | |
Gross Profit Margin | 0.52 | 0.55 |
Current Procept Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Procept analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Procept analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
46.38 | Strong Buy | 8 | Odds |
Most Procept analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Procept stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Procept Biorobotics Corp, talking to its executives and customers, or listening to Procept conference calls.
Procept Stock Analysis Indicators
Procept Biorobotics Corp stock analysis indicators help investors evaluate how Procept Biorobotics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Procept Biorobotics shares will generate the highest return on investment. By understating and applying Procept Biorobotics stock analysis, traders can identify Procept Biorobotics position entry and exit signals to maximize returns.
Begin Period Cash Flow | 225.7 M | |
Long Term Debt | 51.3 M | |
Common Stock Shares Outstanding | 47.3 M | |
Total Stockholder Equity | 280.8 M | |
Property Plant And Equipment Net | 49 M | |
Cash And Short Term Investments | 257.2 M | |
Cash | 257.2 M | |
Accounts Payable | 13.5 M | |
Net Debt | -178 M | |
50 Day M A | 83.658 | |
Total Current Liabilities | 45.9 M | |
Other Operating Expenses | 245.4 M | |
Non Current Assets Total | 54.1 M | |
Non Currrent Assets Other | 4 M | |
Stock Based Compensation | 19.1 M |
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.